OTC & Nutraceuticals US

US Smoking Cessation Products Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

US Smoking Cessation Products Market Industry Trends and Forecast to 2034: Segmented by (Product, Form, Distribution Channel, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

US · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $1.97 Bn Placeholder estimate
Estimate 2025 $2.03 Bn 46% of the global market
Projected 2034 $2.60 Bn 28.2% Adds $571.9 Mn over 9 forecast years
CAGR 2025–2034 2.8% Faster than 10% of 82 OTC & Nutraceuticals markets here
Key players 5
  • US is 45.96% of the global market.
  • In North America, the largest is US (this report) at $2.03 Bn.
  • Fastest growing: Canada at 5.1% a year.
  • US ranks 1st of 2 by size in North America.

Market size projection

US

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$571.9 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Smoking Cessation Products Market market size by year, US
YearMarket sizeChange that yearSince 2025
2024 (estimate) $1.97 Bn — —
2025 (base) $2.03 Bn +$55.2 Mn —
2026 (forecast) $2.08 Bn +$56.8 Mn +2.8%
2027 (forecast) $2.14 Bn +$58.3 Mn +5.7%
2028 (forecast) $2.20 Bn +$60.0 Mn +8.6%
2029 (forecast) $2.26 Bn +$61.7 Mn +11.7%
2030 (forecast) $2.33 Bn +$63.4 Mn +14.8%
2031 (forecast) $2.39 Bn +$65.2 Mn +18%
2032 (forecast) $2.46 Bn +$67.0 Mn +21.3%
2033 (forecast) $2.53 Bn +$68.9 Mn +24.7%
2034 (forecast) $2.60 Bn +$70.8 Mn +28.2%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

US Smoking Cessation Products Market Analysis at a glance
Market size, 2025$2.03 Bn placeholder estimate
Forecast, 2034$2.60 Bn placeholder estimate
Growth (CAGR), 2025–20342.8% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsProduct, form and distribution channel (see all)
Key playersHaleon PLC, Johnson & Johnson, Pfizer Inc., Perrigo Company plc, Cipla Inc. (see all)
Regulator in the USFDASource: US Food and Drug Administration. Checked 14 Nov 2026.Source: US Food and Drug Administration. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The US Smoking Cessation Products Market Analysis Executive Summary

Smoking cessation products help people quit smoking, including nicotine patches, gums, sprays, medicines and quit apps.

Key segments of the smoking Cessation Products market include product (Nicotine Replacement Therapy, Prescription Drugs and Digital Quit Programs) and form (Patches, Gum and Lozenges and Sprays and Inhalers).

Bar chart: US Smoking Cessation Products market size, 2024–2034, placeholder estimates. $1.97 Bn in 2024, $2.03 Bn in 2025 and $2.60 Bn in 2034, 2.8% CAGR.
US Smoking Cessation Products market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

US Smoking Cessation Products Market Dynamics

Market Growth Drivers

More surgery and intensive care, rising infection risks, new specialty medicines and the growth of hospital pharmacy services are driving the smoking Cessation Products market.

Opportunity

Ready-to-use formulations, biosimilars and supply security programmes give the smoking Cessation Products market room to grow.

Market Restraints

Drug shortages, price controls, generic competition and strict hospital budgets hold back the smoking Cessation Products market.

Competitive Landscape for Smoking Cessation Products Market in US

The smoking Cessation Products market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Smoking Cessation Products Market in US

Smoking Cessation Products in the US: rules and health figures

New drugs need approval from the US Food and Drug Administration (FDA); many over-the-counter medicines are sold under FDA monographs instead.⁠[1] Dietary supplements do not need FDA approval before sale; under the Dietary Supplement Health and Education Act of 1994 (DSHEA), the FDA acts against unsafe or mislabelled products.⁠[2] Smoking (adults): 15.8% of adults in 2024, the latest WHO figure for the US.⁠[3]

[1] US Food and Drug Administration. Checked 14 Nov 2026.

[2] US Food and Drug Administration. Checked 14 Nov 2026.

[3] WHO Global Health Observatory, Smoking (adults) (% of adults). Retrieved 15 Nov 2026.

Policy changes and Reimbursement scenario

Food and supplement rules, labelling and health-claim regulations govern smoking Cessation Products products. Authorities such as the US FDA, EFSA and national food safety bodies set what can be sold and claimed in US.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Smoking Cessation Products right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, WHO Global Health Observatory, World Bank. Fetched 15 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Smoking Cessation Products in context

The US compared

  • Smoking (adults): 15.8% of adults (2024). World: 20.3% of adults (2024).[1]
  • Health spending per person: 13,473 US$ per person (2023). World: 1,317 US$ per person (2023).[2]
  • Doctors: 3.68 per 1,000 people (2022). World: 1.86 per 1,000 people (2022).[3]

[1] World Bank Open Data, Smoking (adults) (% of adults). Retrieved 15 Nov 2026.

[2] World Bank Open Data, Health spending per person (US$ per person). Retrieved 15 Nov 2026.

[3] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Smoking Cessation Products market in the US?
Placeholder estimate: about $2.03 Bn in 2025, rising to about $2.60 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Smoking Cessation Products market in the US growing?
Placeholder estimate: about 2.8% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Smoking Cessation Products market report cover?
The report splits the market by product (Nicotine Replacement Therapy, Prescription Drugs, Digital Quit Programs), form (Patches, Gum and Lozenges, Sprays and Inhalers, Tablets) and distribution channel (Supermarkets and Hypermarkets, Pharmacies and Drug Stores, Online Retail, Specialty Stores).
Who are the key players in the Smoking Cessation Products market?
Key players include Haleon PLC, Johnson & Johnson, Pfizer Inc., Perrigo Company plc and Cipla Inc..
What is driving the Smoking Cessation Products market?
More surgery and intensive care, rising infection risks, new specialty medicines and the growth of hospital pharmacy services are driving the smoking Cessation Products market.
Who regulates Smoking Cessation Products in the US?
New drugs need approval from the US Food and Drug Administration (FDA); many over-the-counter medicines are sold under FDA monographs instead. Dietary supplements do not need FDA approval before sale; under the Dietary Supplement Health and Education Act of 1994 (DSHEA), the FDA acts against unsafe or mislabelled products. Source: US Food and Drug Administration. Checked 14 Nov 2026. Source: US Food and Drug Administration. Checked 14 Nov 2026.
What does WHO report for the US?
Smoking (adults): 15.8% of adults in 2024, the latest WHO figure. Source: WHO Global Health Observatory, Smoking (adults) (% of adults). Retrieved 15 Nov 2026.
How many people in the US are 65 or older?
18.4% of people were 65 or older in 2025. Source: World Bank Open Data, Population ages 65 and above (% of total population), from UN population estimates. Retrieved 15 Nov 2026.
How much research is published on Smoking Cessation Products?
PubMed lists 9,665 papers on Smoking Cessation Products added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related OTC & Nutraceuticals reports in US

See all

Related on smoking and respiratory

See the topic